BiVictriX Therapeutics Ltd (“BVX”) is an emerging biotechnology company leveraging clinical experience and its proprietary discovery engine to advance a new class of highly cancer-selective, next-generation precision cancer therapies in one of the fastest-growing markets in oncology. BiVictriX’s first-in-class Bi-Cygni® bispecific Antibody Drug Conjugates (“ADCs”) combine superior efficacy with substantially improved cancer-selectivity and safety to provide opportunities for prolonged dosing and greater efficacy in the clinic. The Company is advancing its pipeline to deliver the future of cancer care across a broad range of haematological and solid cancer indications in areas of high unmet medical need.
BiVictriX Therapeutics Limited
BVX:JPJ / 10.50 GBX
Professional, scientific & technical services
MBF
About the Company
Company Details
Incorporated15/02/2016
Admission Date11/09/2024
Securities in Issue94,133,948
Market Cap£9.8m
Contact Details
Email
AddressMereside Alderley Park, Alderley Edge, Manchester SK10 4TG
Latest News
Documents & Downloads
Other Contacts
Share Registrars Limited (Registrar)
Share Registrars Limited
The Courtyard
17 West Street
Farnham
Surrey GU9 7DR
Company Snapshot
StatusLive
Price10.50 GBX
Offer Interest10.00 GBX
TradingContinous
MarketMBF
TickerBVX:JPJ
ClassOrd
SettlementCREST
IndustryProfessional, scientific & technical services
CountryUnited Kingdom
Company Number13470690
ISINGB00BNXH3K91
CurrencyGBX
Trade History
| Date | Quantity | Mid Price |
Type
Legend: AT - Automatic Trade AX - Agency Cross PI - Primary Issuance NT - Negotiated Trade UT - Uncrossing Trade |
|---|---|---|---|
| 04/02/2025 | 3,763 | 10.50 | |
| 18/10/2024 | 48,282 | 10.50 | |
| 30/09/2024 | 50,000 | 11.50 | |
| 16/09/2024 | 100,000 | 11.00 | |
| 16/09/2024 | 150,000 | 11.00 |
1
Leadership Team
Dr Michael Kauffman
Non-Executive Chairman
Tiffany Thorn
Chief Executive Officer
Petter Veiby
Non-Executive Director
Transacting on JP Jenkins
'Trading' on JP Jenkins is done via a matched bargain facility, this means that on instruction from your 'Broker' we will endeavour to match your shares against other buyer(s) or seller(s) who are also looking to transact. Requests to trade are performed on an availability basis, should an instruction be cancelled, altered or amended in anyway by an instruction from your broker then it shall lose its active place in the queue and reset to the end of list. JP Jenkins receives orders from brokers electronically via a FIX message or should your broker not have a FIX connection to our platform via telephone. If you do not have a UK registered stockbroker you will find a list of brokers that we have worked with to download here. You will also find a list of UK brokers at the bottom of this page and their contact details should you need to appoint one. JP Jenkins can ONLY take instruction to transact from a UK-registered stockbroker and cannot offer investment advice into companies displayed on our website. If you are unsure about trading please consult a financial advisor or wealth manager to assist you in determining what is right for you.